LBIO Financials 07/16/2014 17:22:03 Lion Biotechn

LBIO Financials 07/16/2014 17:22:03
Lion Biotechnologies, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue 16,656 - - -
Gross Profit (16,656) - - -
Operating Expenses
Research and Development 1,329 1,656 1,756 171
Sales, General and Admin. 4,655 6,477 19,303 644
Non-Recurring Items - - 160 -
Other - - - -
Operating Income (22,641) (8,133) (21,218) (815)
Income From Continuing Operations
Add'l Income/Expense Items (2,296) 6,747 (4,324) (793)
Earnings Before Interest and Tax (24,937) (1,386) (25,543) (1,608)
Interest Expense 445 1,922 152 -
Earnings Before Tax (25,381) (3,308) (25,694) (1,608)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (25,381) (3,308) (25,694) (1,608)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (25,381) (3,308) (25,694) (1,608)
Preferred Stock and Other Adjustments (8,462) - - -
Net Income Applicable to Common Shareholders (33,843) (3,308) (25,694) (1,608)